U.S. Health and Human Services
Pain Management Report
The U.S. Health and Human Services Pain Management Best Practices Inter-Agency Task Force developed a report to identify gaps and propose updates to best practices and recommendations for chronic and acute pain management. In this report, unique issues that affect pain for special populations including children, older adults, women, and individuals with sickle cell disease were discussed. Please see pdf document for more detailed information related to individuals with SCD
The complete report can be accessed at https://www.hhs.gov/ash/advisory-committees/pain/reports/index.html.
Final Report Resource Kit
The Task Force put together a resource kit that includes a set of factsheets and infographics that summarize information from the final report. The resources listed below can be used in PowerPoint presentations, newsletters, or on social media accounts.
- Overview – of the Task Force’s findings and background in light of the ongoing opioid crisis. Factsheet – PDF
- Policymakers – at the Federal and State levels play a critical role in improving the lives of those living with chronic pain. Factsheet – PDF
- Special Populations – with unique challenges associated with acute and chronic pain, include children/youth, older adults, women, pregnant women, individuals with chronic relapsing pain conditions, racial and ethnic populations, active duty military, reserve service members, Veterans, patients with cancer-related pain, and patients in palliative care. Factsheet – PDF
- Access to Care – learn more about barriers such as lack of coverage, medication and pain management specialist shortages and stigma. Factsheet – PDFand Infographic – PDF
- Stigma – can serve as a significant barrier to adequate pain treatment – and can affect patients, families, caregivers, and even clinicians. Factsheet – PDFand Infographic – PDF
- Education – for patients, clinicians, and policymakers is critical to the delivery of effective, patient-centered pain management. Factsheet – PDFand Infographic – PDF
Sickle Cell Care Coordination Initiative
Who we are . . .
The Sickle Cell Care Coordination Initiative (SCCCI) seeks to improve care provided to youth and adults with sickle cell disease in Northern California. We are one of 8 programs in the U.S. funded by the National Heart, Lung and Blood Institute (NHLBI) to use implementation science to improve outcomes for individuals with sickle cell disease between the ages of 15 and 45 years.
The SCCCI brings together experts in sickle cell disease clinical care and clinical research, health services research, implementation and participatory research and emergency medicine. Our core team also includes individuals with sickle cell disease, their family members and dedicated community members.
Our aims are to:
- increase the number of youth and adults with sickle cell disease who receive preventive care;
- support providers so they increase their adherence with evidence based guidelines for sickle cell disease care; and
- support youth and adults with sickle cell disease to access needed resources within their communities to improve their quality of life and quality of care. Our primary goal is to decrease the preventable morbidity and mortality that this population is vulnerable to.
The work of the SCCCI will take place in Alameda, Contra Costa, Sacramento, San Francisco and Solano counties.
Why Implementation Science?
NHLBI made a commitment to funding the Sickle Cell Disease Implementation Consortium in response to evidence that only a fraction of discovery science reaches patients in clinical practice1. Americans receive, on average, only half of recommended preventive, acute and long-term quality health care. There is no better example of this issue than sickle cell disease, where evidence based guidelines are greatly underutilized2. As a result, adults with sickle cell disease experience high mortality, severe pain, progressive decline in functional status and lack of access to knowledgeable care. The barriers to care, on the parts of both patients with sickle cell disease and their providers, are poorly understood, although some patients face distrust and discrimination when they do try to seek care. Implementation science takes a “systems approach” to improve health outcomes, engaging multiple sectors and multiple modalities to define and prioritize health outcomes and care issues, and to identify barriers to care. The Sickle Cell Disease Implementation Consortium is the first research program to use implementation science to identify and address barriers to quality care in sickle cell disease.
What is the plan?
We conducted a needs-based community assessment of barriers to care for youth and adults with sickle cell disease. Participants were patients with sickle cell disease, the providers who care for them, directors of services where they seek care, and interested community members who had ideas about the needs of patients with sickle cell disease and how to address them. We selected providers and people with sickle cell disease to provide us with this information via focus group or individual interviews. We also asked providers and people with sickle cell disease to complete a survey about the issues.
Information from the needs assessment is informing the next phases of the SCCCI. We are creating a registry of youth and adults within our five county area in order to track inpatient, outpatient and emergency use; complications; and such factors linked with health as access to housing, education and good medical care. We are designing interventions informed by the needs assessment focused on improving the quality of acute and preventive care and patient self-management. By working with the other sites within the Sickle Cell Disease Implementation Consortium, we will be able to track our intervention outcomes across one of the largest U.S. cohorts of youth and adults with sickle cell disease to date.
The registry is the next crucial step for the Sickle Cell Care Coordination Initiative. We are collecting information on symptoms, treatments, and concerns about medical care for youth and adults with sickle cell disease. This information will help us to see where improvements can be made in the medical care system, and with regard to community support, for sickle cell disease.